Fig. 7From: Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphomaMix + GalCer vaccine induces specific IgG antibodies that recognize 4TOO tumor cells. 4TOO and A20 tumor cells were incubated with serum samples of naive, untreated and Mix + GalCer treated groups and the relative specific IgG antibody levels were analyzed by flow cytometry (n = 3 per group) and normalized using the value of naive serum samples. *p < 0.05Back to article page